Amplification of MET is often responsible for the activation of MET signalling, with such amplification occurring most frequently (10–20%) in gastric cancer (Kuniyasu et al, 1992; Nessling et al, 1998; Sakakura et al, 1999). Here, MET is linked to gastric cancer.